µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
 

ȸ»ç¸í
(ÁÖ)·¹ÄÚ¸£´ÙƼÄÚ¸®¾Æ
ȨÆäÀÌÁö
ÁÖ¼Ò
¼­¿ï °­³²±¸ °­³²´ë·Î 302 4Ãþ
ÀüÈ­/Æѽº¹øÈ£
0507-1366-1391 /
 
°Ë»öµÈ Á¦Ç°¸í (À¯ÅëÁßÀÎ Á¦Ç°) ÃÑ 3°³
Á¦Ç°¸í   ¼ººÐ/ÇÔ·® ±¸ºÐ º¸Çè
½Ç¹ÝÆ®ÁÖ100mg(½ÇÅö½Ã¸¿, À¯ÀüÀÚÀçÁ¶ÇÕ)

siltuximab 100mg

Àü¹®±Þ¿©
½Ç¹ÝÆ®ÁÖ400mg(½ÇÅö½Ã¸¿, À¯ÀüÀÚÀçÁ¶ÇÕ)

siltuximab 400mg

Àü¹®±Þ¿©
ÄâÁö¹ÙÁÖ4.5mg/mL(µð´©Åö½Ã¸¿º£Å¸) 4.5mL

Dinutuximab beta 20.25mg

Àü¹®ºñ±Þ¿©
[1]
°Ë»öµÈ Á¦Ç°¸í (À¯ÅëµÇÁö ¾Ê´Â Á¦Ç°) ÃÑ 0°³
Á¦Ç°¸í ¼ººÐ/ÇÔ·® ±¸ºÐ »ý»ê¿©ºÎ
°Ë»ö°á°ú°¡ ¾ø½À´Ï´Ù.